date,title,source
Oct-23-18,Cramer's lightning round: If you want to invest in non-op...,CNBC Videos
Oct-31-18,Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management,PR Newswire
Nov-07-18,"Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Heron Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,"Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress",PR Newswire
Nov-12-18,U.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics,PR Newswire
Nov-12-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-20-18,Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference,PR Newswire
Nov-21-18,When Will Heron Therapeutics Inc (NASDAQ:HRTX) Become Profitable?,Simply Wall St.
Nov-26-18,Today's Research Reports on Trending Tickers: Cronos Group and Heron Therapeutics,ACCESSWIRE
Nov-27-18,"Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-29-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Supernus Pharmaceuticals,ACCESSWIRE
Dec-31-18,Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Dec-31-18,Heron stock up 4.3% after opioid alternative granted priority review designation from FDA,MarketWatch
Dec-31-18,"FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management",PR Newswire
Jan-02-19,"Company News For Jan 2, 2019",Zacks
Jan-02-19,Heron Gains on Priority Review Designation for Pain Drug,Zacks
Jan-03-19,90% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study,PR Newswire
Jan-07-19,Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises,PR Newswire
Jan-30-19,"New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Jan-31-19,Today's Research Reports on Trending Tickers: Mylan and Heron Therapeutics,ACCESSWIRE
Feb-05-19,Heron Therapeutics Announces Retirement of Robert Rosen as President,PR Newswire
Feb-06-19,"How Much Did Heron Therapeutics, Inc.s (NASDAQ:HRTX) CEO Pocket Last Year?",Simply Wall St.
Feb-20-19,Heron Therapeutics to Present at the 8th Annual Leerink Partners Global Healthcare Conference,PR Newswire
Feb-22-19,"Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-22-19,Heron Therapeutics: 4Q Earnings Snapshot,Associated Press
Feb-22-19,"Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress",PR Newswire
Mar-04-19,Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference,PR Newswire
Mar-05-19,"Report: Exploring Fundamental Drivers Behind Caesars Entertainment, Party City Holdco, Rowan Companies, TiVo, Heron Therapeutics, and Cimarex Energy  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Mar-11-19,77% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study in Bunionectomy,PR Newswire
Apr-01-19,Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management,PR Newswire
Apr-02-19,"What Kind Of Share Price Volatility Should You Expect For Heron Therapeutics, Inc. (NASDAQ:HRTX)?",Simply Wall St.
Apr-02-19,4 Biotech Stocks With Major Catalysts in April,Motley Fool
Apr-03-19,3 Promising Small Biotech Stocks to Watch,TheStreet.com
Apr-29-19,Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options,Zacks
Apr-30-19,Heres What Hedge Funds Think About Heron Therapeutics Inc (HRTX),Insider Monkey
